As a biological example, we chose to investigate a Vemurafenib resistant melanoma cell line, LOX-IMVI, as compared to a sensitive cell line A375 [16,17] with the goal of implicating mutations that may be affecting LOX-IMVI’s response to the drug. Here, LOX is linked to melanoma.